White/Brown Bagging

Restricts a health plan from requiring a beneficiary to use a drug dispensed through a PBM’s specialty pharmacy rather than a hospital pharmacy for specialty drugs that need to be physician administered.

Filter by Document Type

2025 CT Prescription Drug Task Force Comment Letter

View Document >

White Bagging Dispensing: Convenient and Less Costly (Report)

View Document >

White Bagging White Paper, Nov. 2021, Marwood Group

View Document >

National Comprehensive Cancer Network Task Force Report: Specialty Pharmacy

View Document >

White and Brown Bagging Emerging Practices, Emerging Regulation, National Association of Boards of Pharmacy, 2018

View Document >

APPENDIX: White Bagging Dispensing (Report)

View Document >

PBM Management of Specialty Pharmacies (Infographic)

View Document >

RI S 870 Comment Letter (2023)

Comment letter on RI S 870, a bill addressing white bagging

View Document >

KS Board of Pharmacy/HB 2184 Comment Letter (2023)

Comment Letter requesting the Governor’s support of provisions of HB 2184, which would counter proposed board of pharmacy prohibition of white bagging by delaying enforcement

View Document >

NM SB 14 Comment Letter (2023)

Comment letter for NM SB 14, which includes provisions relating to Dispensing Fees, Steering, AWP, White Bagging, Disclosure, Fiduciary, and Spread Pricing

View Document >

MO SB 26 Comment Letter (2023)

Comment letter addressing white bagging, biosimiliars, and 340b provisions in MO SB 26.

View Document >

KS Board of Pharmacy Comment Letter (2023)

A comment letter sent to the Kansas Board of Pharmacy concerning its proposed white bagging provisions.

View Document >

Pharmaceutical Care
Management Association

325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700

©2024 PCMA. All Rights Reserved.